With over 25 years of experience in the pharmaceutical industry, John is a seasoned leader in pre-commercial asset value development, commercial launch planning, pricing and market access for orphan medicines. He has a strong track record of delivering successful launches and creating value for biotech clients across multiple geographies and therapeutic areas.He is currently the Chief Commercial Officer at Oranda Therapeutics, a European privately held company focused on acquiring, developing and commercializing innovative treatments for patients in areas of high unmet need. He leads a launch team with a deep collective understanding of the critical success factors that drive excellence in commercial execution. He is passionate about bringing novel therapies to the market and improving the lives of people with rare and complex diseases.